ArticleEuropean journal of microbiology & immunology2017

Low Neurotoxicity of ONX-0914 Supports the Idea of Specific Immunoproteasome Inhibition as a Side-Effect-Limiting, Therapeutic Strategy.

Laura von Brzezinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.